Skip to main content
. 2020 Dec 17;11:580481. doi: 10.3389/fphar.2020.580481

TABLE 1.

Patients information.

Patient Gender Age (years) β-blocking Drug QTc (ms) QTc leaving 90% of control QTc below (ms) QTc increment (%)
1 Male 1 Nadolol 542 434 24.9
(7 months) 516 434 18.9
2 Female 29 Nadolol 503 437 15.1
498 437 14.0
3 Female 11 Nadolol 555 434 27.9
528 434 21.7
4 Female 2 Propranolol 471 434 8.5
556 434 28.1
Average 19.9

This table contains anonymized relevant data of our four patients (from 1 to 4), namely, from left to right, their assigned code, gender, age (in years), the name of the administered β-blocking drug, registered QTc interval values (in ms), reference QTc values (in ms) and calculated QTc increment (in %). The last row shows the average QTc increment.